Sapheon has filed with the FDA the first module of its premarket approval application for VenaSeal Sapheon, a device used for treating varicose veins. The system, which already has CE mark approval in Europe, is undergoing an investigational device exemption trial in the U.S.
Sapheon seeks FDA approval for device to treat varicose veins
SmartBrief Job Listings for Health Care
|Account Management and Product Development Specialist||
Sharp Health Plan
|San Diego, CA|
|Chief Operating Officer||
Presence Health Partners
|Des Plaines, IL|
|Sr. Business Systems Analyst||
|Sr. Reimbursement Analyst||
Olympus America Inc.